September 13, 2011 |
A 2007 executive order by Texas Gov. Rick Perry has become the latest post-debate headache for the Republican presidential front-runner, who was accused of "crony capitalism" Tuesday by Rep. Michele Bachmann. The fight over requiring vaccinations for young girls — which surfaced in Monday's Florida debate — involved government prerogatives and cancer. But it also had a strong moral subtext: Bachmann and other social conservatives objected to forcible inoculations against a disease spread by sexual activity, while Perry defended himself with the language of the antiabortion movement.
September 13, 2011 |
The HPV vaccine, which protects women against the human papilloma virus, is in the news once again, thanks to the recent GOP debate in which presidential candidate Michele Bachmann criticized Texas Gov. Rick Perry's proposed mandate of the vaccine and called it "...what potentially could be a very dangerous drug. " But that's not how most mainstream medical organizations in the U.S. see the HPV vaccine, approved in 2006 to prevent the spread of the virus, which can cause genital warts and may lead to cervical cancer.
September 8, 2011 |
The HPV vaccine, approved in 2006, requires three shots over a six-month period -- a regimen that is inconvenient and costly. But a new study shows a two-dose vaccine may work as well. The vaccine prevents infection from certain strains of the human papilloma virus, which can cause cervical cancer. It is considered revolutionary because it's the first vaccine to prevent a type of cancer. (It was even a topic of Wednesday night's Republican presidential candidates' debate because of Texas Gov. Rick Perry's proposal to mandate the vaccine in his state.)
August 26, 2011 |
Popular fears about vaccines -- including the belief that the measles, mumps and rubella shot causes autism -- are unfounded, a study released Thursday by the Institute of Medicine reported. But another report released Thursday, from the Centers for Disease Control and Prevention, noted with some alarm that many parents still shun another recommended vaccine: the three-shot series that protects against human papilloma virus (HPV), a widespread sexually transmitted virus, some types of which can cause cervical cancer.
November 18, 2010 |
A Food and Drug Administration advisory committee Wednesday recommended that the agency extend approval of the human papillomavirus (HPV) vaccine Gardasil for protection against anal cancer in males and females ages 9 through 26. The agency is not required to follow the recommendations of its advisory committees, but it generally does so. Anal cancer is relatively uncommon, striking about 5,000 Americans each year. About 90% of cases are thought to be caused by HPV. Gardasil protects against four of the most common strains of HPV. It is already licensed for protection against cervical cancer in women and against genital warts in both sexes ages 9 to 26. The new indication was based primarily on a clinical trial conducted among 4,065 men, 602 of them gay. Patients were randomly assigned to receive either three doses of the vaccine or a placebo.
November 9, 2010 |
The HPV vaccine was approved in 2006 as the first vaccine that can prevent a type of cancer. The vaccine protects against several common strains of human papilloma virus, which causes genital warts and can lead to cervical cancer. However, a new study show that a majority of young women who are eligible for the vaccine are either not getting it or are not following the three-shot protocol to be fully immunized. Researchers from the University of Maryland analyzed data from 9,658 teenagers and young women who were eligible for the HPV vaccination at the University of Maryland Medical Center between August 2006 and August 2010.
November 17, 2009 |
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. Girls and women seeking to become legal permanent U.S. residents were required to get at least the first dose of the vaccine against human papillomavirus. Starting Dec. 14, the HPV vaccine will no longer be on the list of immunizations that immigrants must receive before getting their green card, the federal Centers for Disease Control and Prevention said Friday.
December 4, 2008 |
A large study of girls and young women who received the cervical cancer vaccine Gardasil has found only three confirmed cases of allergic reaction out of 380,000 shots. The study, published today in the British Medical Journal, was based on vaccination data from Australia, which has had a nationwide program to vaccinate females ages 12 to 26 in schools since April 2007.
August 11, 2008 |
Sandra Levy wants to do everything she can to safeguard the health of her 11-year-old daughter -- and that, of course, includes cancer prevention. She has had her child inoculated with one shot of Gardasil, the human papilloma virus vaccine that may prevent cervical cancer. But now, she says, she has serious reservations about going ahead with the next two injections of the course. "It's very confusing, and we really don't know if it's 100% safe," says Levy, of Long Beach.
May 14, 2007 |
When Merck launched a multimillion-dollar marketing campaign last year to promote Gardasil, its new vaccine to prevent cervical cancer, company officials probably did not anticipate that its signature phrase -- "one less" -- would apply not just to malignancies but also to physicians. Yet that slogan has come to symbolize the response of doctors.